Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,506.15
(
0.44%
)
US TECH 100
29,117.20
(
1.45%
)
Dow Jones
50,389.52
(
-0.38%
)
Brent Oil
96.74
(
-4.38%
)
Bitcoin
75,933.14
(
-1.73%
)
News Focus
News Focus
Post# of 448100
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Chromosome

Send PM Follow Ignore
Followers 6
Posts 389
Boards Moderated 0
Alias Born 02/09/2022

Chromosome

Re: Number sleven post# 431202

Wednesday, 12/04/2024 7:16:47 PM

Wednesday, December 04, 2024 7:16:47 PM

Post# of 448100
Sleven, to add to that I think ANRN is an unborn among biotechs. The reason biotechs fail is because the science fails. If n that case nothing will fix the failure. In AMRN’s case, it’s a business execution and market development issue. If these two components fail, the asset is still valuable and someone will find a way to make it successful.
All my opinion and no endorsement intended.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News